Prediction of Conversion from Clinically Isolated Syndrome to Multiple Sclerosis According to Baseline Characteristics: A Prospective Study
- PMID: 30042636
- PMCID: PMC6045808
- DOI: 10.29399/npa.12667
Prediction of Conversion from Clinically Isolated Syndrome to Multiple Sclerosis According to Baseline Characteristics: A Prospective Study
Abstract
Objective: Clinically isolated syndrome (CIS) is a clinical state that proceeds with inflammation and demyelination, suggestive of multiple sclerosis (MS) in the central nervous system in the absence of other alternative diagnoses. The purpose of this study was to determine in a prospective cohort, the predictor factors in conversion from CIS to MS on the basis of clinical, magnetic resonance (MR) imaging and cerebrospinal fluid (CSF) findings.
Methods: Forty-one CIS patients were included in this study and followed up for at least two years.
Results: Clinically, polysymptomatic or sensorial involvement, good prognostic factors and complete response to pulse therapy were found to be of prognostic value in conversion to MS. A greater presence of oligoclonal bands in CSF was identified in the converted group (92.8%). In terms of localization, presence of callosal lesion (71.4%), periventricular lesion (97.1%), Gd-enhanced lesion (48.6%), black hole (54.2%) and brainstem lesion (57.1%) was statistically significant in terms of conversion to MS.
Conclusion: A carefully performed neurological assessment of symptoms and signs, and evaluation of lesions on MR combined with CSF findings are important for identifying the risk of conversion to MS. This information may be useful when considering treatment in CIS patients instead of waiting for conversion to MS.
Keywords: Clinically isolated syndrome; conversion; multiple sclerosis; prognosis.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures
References
-
- Brex PA, O'Riordan JI, Miszkiel KA, Moseley IF, Thompson AJ, Plant GT, Miller DH. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology. 1999;53:1184–1190. - PubMed
-
- Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I. natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005;4:281–288. - PubMed
-
- Jacobi C, Hähnel S, Martinez-Torres F, Rieger S, Jüttler E, Heiland S, Jarius S, Meyding-Lamadè U, Storch-Hagenlocher B, Wildemann B. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis:impact on dissemination in space and time. Eur J Neurol. 2008;15:1359–1364. - PubMed
-
- Noseworthy JH, Lucchinetti C, Rodrı´guez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343:938–952. - PubMed
-
- Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000;343:898–904. - PubMed
LinkOut - more resources
Other Literature Sources